Germany's government has proposed requiring workers to obtain a doctor's note on the first day of illness, sparking sharp criticism from medical professionals who say the policy endangers public health.
The German Medical Association calls the plan "borders on madness," warning that forcing sick people to visit clinics immediately places both patients and healthcare workers at risk. The proposal would eliminate the current three-day grace period that allows employees to stay home without documentation before needing medical verification.
Dr. Klaus Reinhardt, head of the German Medical Association, expressed concern that the policy would overwhelm practices with patients seeking notes for minor illnesses. His organization argues that people with contagious conditions should isolate at home rather than travel to medical facilities, potentially spreading infection to vulnerable patients and staff.
The German government introduced the measure as part of efforts to reduce sickness absence rates and boost workplace productivity. Officials frame the change as a way to discourage unnecessary absences and ensure employees are genuinely ill.
However, medical experts counter that the policy contradicts infection control principles. Patients with colds, flu, or other contagious conditions transmit illness more easily when traveling and sitting in waiting rooms. Requiring immediate in-person doctor visits creates a public health liability rather than addressing workplace attendance issues.
The row reflects a broader tension between employer interests and evidence-based medical practice. Telemedicine offers a potential compromise, allowing doctors to assess patients remotely and issue notes without unnecessary exposure risks. Some healthcare systems already use this approach successfully.
The controversy highlights how well-intentioned policies can backfire without input from medical professionals. Germany's doctors emphasize that trusted sickness protocols exist for good reason. They've called for the government to reconsider the plan and explore alternatives that balance legitimate workplace concerns with patient safety and infection prevention.
The outcome remains uncertain as stakeholders continue debating whether the policy will proceed.